Stay updated on Amifampridine in MuSK-MG Clinical Trial
Sign up to get notified when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.

Latest updates to the Amifampridine in MuSK-MG Clinical Trial page
- CheckyesterdayChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1, while the study page continues to show a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual study record content and preventing access to the study details.SummaryDifference18%

- Check57 days agoChange DetectedThe page shows a new revision label, moving from v3.6.5 to v3.6.6, indicating a small update to the page’s version. This change reflects an internal update rather than a substantive modification to the information presented.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.6.5 is shown on the page, replacing the previous v3.6.4. This appears to be a minor build/release update and does not change the study content or data presented.SummaryDifference0.1%

Stay in the know with updates to Amifampridine in MuSK-MG Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.